COMPARING TWO DIFFERENT TREATMENT MODALITIES FOR MANAGEMENT OF ACNE SCARS
- Conditions
- Health Condition 1: L905- Scar conditions and fibrosis of skin
- Registration Number
- CTRI/2023/06/053825
- Lead Sponsor
- SANIKA SUNIL TANAWDE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients willing to participate in the study.
2.Patients in the age group of 18-60 years of age.
3.Patients with post-acne scars in the maxillofacial region.
Pregnant and lactating women.
Patients with history of systemic diseases which affect the lipid profile. (Diabetes mellitus, thyroid dysfunction, cardiovascular diseases, & liver disorders).
Patients with post-herpetic scars/post-varicella scars, burn scars in maxillofacial region.
Patients on corticosteroid or aspirin therapy for past 1 year.
Patients with keloids, family history of keloids.
Patients with bleeding disorder.
Patients with active viral or bacterial infection of face or active inflammatory lesions of face.
Patients with malignant tumours of face.
Patients with diseases like HIV, tuberculosis.
Patients undergoing any cosmetic treatment or taking any medication for facial aesthetics currently.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in scar gradeTimepoint: Facial photographs to be taken before initiation (day 1) of and 1 month after completion of <br/ ><br>final treatment (day 60). <br/ ><br> <br/ ><br>Clinical assessment to be done on 3rd day, 7th day <br/ ><br>, 1 month and 2 months. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Comparing which of the above two mentioned treatments are betterTimepoint: Facial photographs to be taken before initiation (day 1) of and 1 month after completion of <br/ ><br>final treatment (day 60). <br/ ><br> <br/ ><br>Clinical assessment to be done on 3rd day, 7th day <br/ ><br>, 1 month and 2 months. <br/ ><br>